Polyketide Biosynthesis Genes

Simple SummaryContent extracted from patent full text and abstract with AI.

This invention discloses a novel method for selectively isolating genes responsible for the biosynthesis of polyketides, specifically from complex metagenomic samples such as those from marine sponges. The patent describes the identification, nucleic acid, and amino acid sequences of polyketide synthase (PKS) gene clusters involved in the production of compounds like psymberin and mycalamides, as well as accompanying expression systems to produce these bioactive molecules in host organisms. The core of the method involves designing specific primers based on conserved ketosynthase domain motifs for highly selective amplification and isolation of targeted biosynthetic genes.

Use CasesContent extracted from patent full text and abstract with AI.

• Discovery and engineering of new bioactive polyketide compounds for pharmaceutical development (e.g., anti-cancer, anti-bacterial drugs).
• Synthetic biology: Heterologous expression of complex natural products in easily cultured host organisms (such as E. coli or Bacillus species).
• High-throughput screening of environmental (e.g., marine sponge) metagenomes for novel biosynthetic pathways.
• Metabolic engineering for the improved or tailored production of valuable polyketides.
• Functional genomics research to elucidate the roles of specific PKS clusters in natural product biosynthesis.

BenefitsContent extracted from patent full text and abstract with AI.

• Overcomes previous limitations in isolating specific biosynthetic genes from complex metagenomic mixtures, especially when the symbiotic bacteria cannot be cultured directly.
• Enables targeted and highly selective amplification of desired polyketide biosynthesis genes, increasing the efficiency of gene discovery and reducing background noise from unrelated genes.
• Provides complete gene cluster sequences and corresponding expression systems, facilitating the production of valuable polyketide compounds in readily cultivable hosts.
• Supports drug discovery by enabling access to new and complex natural products with pharmaceutical potential.
• Accelerates biotechnological applications by transferring whole biosynthetic systems into model organisms, paving the way for large-scale and sustainable manufacturing of rare natural compounds.

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

The present invention relates to a novel method for selectively isolating polyketide biosynthesis genes from metagenomes. Furthermore, the nucleic and amino acid sequences of the PKS cluster of psymberin and expression systems for producing said polyketide are disclosed for the first time.